Neuspera Medical Inc., headquartered in the United States, is a pioneering company in the medical device industry, specialising in innovative neuromodulation solutions. Founded in recent years, Neuspera has quickly established itself as a leader in the development of advanced technologies aimed at improving patient outcomes in chronic pain management and other neurological conditions. The company’s flagship product, the Neuspera System, is distinguished by its unique, miniaturised design that allows for less invasive procedures and enhanced patient comfort. This cutting-edge technology positions Neuspera Medical at the forefront of the neuromodulation market, with a commitment to transforming the treatment landscape. With a focus on research and development, Neuspera continues to achieve significant milestones, solidifying its reputation as a key player in the evolving field of medical devices.
How does Neuspera Medical Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Neuspera Medical Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Neuspera Medical Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Neuspera Medical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As a result, the company does not inherit any emissions data from a parent or related organization, and there are no industry-standard climate commitments reported.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Neuspera Medical Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
